Journal article
Delta-9-tetrahydrocannabinol may palliate altered chemosensory perception in cancer patients: results of a randomized, double-blind, placebo-controlled pilot trial
Abstract
BACKGROUND: A pilot study (NCT00316563) to determine if delta-9-tetrahydrocannabinol (THC) can improve taste and smell (chemosensory) perception as well as appetite, caloric intake, and quality of life (QOL) for cancer patients with chemosensory alterations.
PATIENTS AND METHODS: Adult advanced cancer patients, with poor appetite and chemosensory alterations, were recruited from two sites and randomized in a double-blinded manner to receive …
Authors
Brisbois TD; de Kock IH; Watanabe SM; Mirhosseini M; Lamoureux DC; Chasen M; MacDonald N; Baracos VE; Wismer WV
Journal
Annals of Oncology, Vol. 22, No. 9, pp. 2086–2093
Publisher
Elsevier
Publication Date
September 2011
DOI
10.1093/annonc/mdq727
ISSN
0923-7534